Olaf Weppner new Managing Director of EIT Health Germany Partner AbbVie Germany
Olaf Weppner will be the new Managing Director of AbbVie Germany as of September 1, 2019. He succeeds Dr. Patrick Horber, who is moving to the company headquarters in Chicago (USA) as Vice President Global Marketing and Commercial Operations.
Olaf Weppner will lead the national organization as Spokesman of the Management Board together with Dr. Stefan Simianer and Thomas Scheidmeir and will be responsible for Marketing and Sales at the German headquarters in Wiesbaden. At the Ludwigshafen site, Simianer and Scheidmeir will continue to head the Research & Development and Production divisions.
Olaf Weppner is originally from Mainz and studied business administration. He joined Abbott in 1999 and AbbVie emerged from Abbott in 2013. He held various positions in sales and marketing, both in Germany and at the company’s US headquarters. He knows the German national organization from his time as Director of the Business Unit Immunology, which is most important for the company. In 2015, Weppner became Managing Director of AbbVie in Switzerland, before moving back to the USA in 2018 as Vice President, Immunology, Global Marketing & Commercial Operations.
“I am very pleased to be returning to Germany for our company in this exciting phase,” said Weppner, commenting on the change: “In the coming years, we will provide a variety of innovative drugs and solutions that will noticeably and sustainably improve patients’ lives. This is what we at AbbVie stand for – and we do it with enthusiasm”.
Read the German press release here